Spousal Relationship (E) Quality and Adjustment to Motherhood in Israel

2019 ◽  
Vol 40 (11) ◽  
pp. 1561-1578
Author(s):  
Miri Kestler-Peleg ◽  
Osnat Lavenda ◽  
Shelli Keren-Leneman ◽  
Karni Ginzburg
Keyword(s):  
Life Satisfaction ◽  
Postpartum Depression ◽  
Positive Affect ◽  
Pregnant Women ◽  
Psychological Adjustment ◽  
Postnatal Period ◽  
Third Trimester ◽  
Spousal Relationship ◽  
The Third ◽  
The Impact

Contemporary families experience the paradox of traditionalism/postmodernism especially in the postnatal period which presents many challenges to couples subsystem. One of them is the change in roles, which often leads to decreased relationships’ equality. This article tests the impact of change in perceived spousal equality after giving birth on relationships’ quality and the implications of the latter for mothers’ psychological adjustment. Participants included 349 Israeli pregnant women who completed self-reported questionnaires at the third trimester of pregnancy (T1) and 5 months postnatal (T2). The questionnaires dealt with perceived spousal equality, relationship’s quality and psychological adjustment (i.e., postpartum depression, negative and positive affect and life satisfaction). Results demonstrated that decrease in perceived equality from T1 to T2 reduced the levels of relationship’s quality, which in turn resulted in a decrease in mothers’ psychological adjustment, 5 months after giving birth. The centrality of spousal relationship for mothers’ psychological adjustment is discussed.

scholarly journals Incidence and prevalence of postpartum depression in a rural community of India

2015 ◽  
Vol 5 (2) ◽  
pp. 11-19 ◽  
Author(s):  
N Shrestha ◽  
P Hazrah ◽  
R Sagar
Keyword(s):  
Depressive Symptoms ◽  
Postpartum Depression ◽  
Pregnant Women ◽  
Rural Community ◽  
Postpartum Period ◽  
Cutoff Score ◽  
Third Trimester ◽  
The Third ◽  
Maternal Suicide

Postpartum depression (PPD) is defined as presence of depressive symptoms in the postpartum period. A seemingly innocuous disorder, if untreated can lead to foeticide or maternal suicide. Unfortunately there are very few studies which have looked into the burden of the disease. The prevalence and incidence of postpartum depression vary across culture, region and communities, with very few studies having addressed the issue, thereby making it difficult to estimate the actual burden of the disease. The present study was undertaken to estimate the incidence and prevalence of postpartum depression in a rural community of India. A cohort of 200 pregnant women were interviewed in the third trimester of pregnancy and subsequently at 6 weeks postpartum to screen for presence and severity of depressive symptoms using BDI, ICD10 and EPDS scores. A cutoff score > 13 was considered as positive for depression in EPDS. The prevalence of PPD was 12% and incidence of PPD 4.4%.

scholarly journals The Relationship between Gestational Weight Gain and Postpartum Depression in Normal and Overweight Pregnant Women

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Fatemeh Dayan ◽  
Nahid Javadifar ◽  
Mitra Tadayon ◽  
Amal Saki Malehi ◽  
Hosein Komeili Sani
Keyword(s):  
Weight Gain ◽  
Postpartum Depression ◽  
Pregnant Women ◽  
Health Care Providers ◽  
First Trimester ◽  
Care Providers ◽  
Third Trimester ◽  
The Third ◽  
Pregnancy And Postpartum ◽  
The Relationship

Objective. To investigate the relationship between weight gain in pregnancy and postpartum depression (PPD) in normal and overweight pregnant women. Methods. The participants of this prospective cohort study were 223 healthy pregnant women with the first trimester body mass index (BMI) between 18.5 and 30 and the gestational age of 10-14 weeks and depressed women were excluded with Beck questionnaire in the first trimester. The evaluation included weight gain at the end of the second and third trimesters and the screening of PPD in 6-8 weeks after delivery by Edinburgh scale. Results. 49 participants were excluded from the study and data from 174 people were analyzed. 32.2% of mothers were scored above 12 in the Edinburgh scale. The only variable associated with depression was the third trimester weight gain (OR 1.17, 95%CI 1.04-1.32). Conclusion. In addition to considering other risk factors for postpartum depression, health care providers should consider the higher probability of PPD in prepregnancy normal and overweight women who have excessive weight gain especially in the third trimester of pregnancy.

scholarly journals The impact of the month pregnant and fetus sex on progesterone and cortisol hormones and lipid profile in the women during the third-trimester pregnancy

2019 ◽  
Vol 24 (1) ◽  
pp. 23
Author(s):  
Wahbi Abdulqader Salman Al-Hamdany ◽  
Sanaa Mohammed Morshed
Keyword(s):  
Pregnant Women ◽  
Lipid Profile ◽  
Third Trimester ◽  
Male Fetus ◽  
Female Fetus ◽  
Blood Samples ◽  
The Third ◽  
Trimester Pregnancy ◽  
Biochemical Compounds ◽  
The Impact

This study was conducted at Salahaddin General Hospital to find out the impact of pregnancy month and the sex of the fetus on progesterone, cortisol hormones and some biochemical compounds (VLDL-C, LDL-C, HDL-C, TG Cholesterol, and Glucose), during the last trimester of the pregnant women. Ninety blood samples were collected from the pregnant women, 5ml blood from each woman, the number of pregnant women during the 7th, 8th and 9th months (34, 29, 27) woman respectively. During the ninth month of pregnancy, there was a significant increase (P≤0.01) in the concentration of cortisol hormone compared with the seventh and eighth month, but the concentration of progesterone hormone decreased significantly (P≤0.01) during the ninth month compared to the seventh and eighth months. The concentrations of (VLDL-C, LDL-C, TG, Cholesterol, and Glucose) increased in the ninth month of pregnancy compared to the seventh and eighth months, while the concentration of the HDL-C increased in the seventh and eighth months compared with the ninth month. There were no significant differences between the male and the female fetus in pregnant women cortisone and progesterone concentrations. The pregnant women with male pregnancy significantly increased compared with the female fetus pregnancy in the (VLDL-C, LDL-C, Glucose) while the female pregnancy significantly increased compared with the male fetus pregnancy (P≤0.05) in concentrations of HDL-C. There are no significant differences observed between the male fetus and female pregnancies in cholesterol concentrations. Conclusion: this study finds out that the ninth month of the pregnancy caused more detriment to the pregnant women and male fetus is more likely to cause stress on the pregnant women than the female fetus.   http://dx.doi.org/10.25130/tjps.24.2019.004

Features of the course and treatment of glaucoma during pregnancy

2020 ◽  
Vol 98 (3) ◽  
pp. 178-184
Author(s):  
T. V. Chernyakova ◽  
A. Yu. Brezhnev ◽  
I. R. Gazizova ◽  
A. V. Kuroyedov ◽  
A. V. Seleznev
Keyword(s):  
Pregnant Women ◽  
Laser Treatment ◽  
Progressive Disease ◽  
Clinical Course ◽  
The Other ◽  
Third Trimester ◽  
The Third ◽  
Chronic Progressive Disease ◽  
Hypotensive Therapy ◽  
Eye Pressure

In the review we have integrated all up-to-date knowledge concerning clinical course and treatment of glaucoma among pregnant women to help specialists choose a proper policy of treatment for such a complicated group of patients. Glaucoma is a chronic progressive disease. It rarely occurs among childbearing aged women. Nevertheless the probability to manage pregnant patients having glaucoma has been recently increasing. The situation is complicated by the fact that there are no recommendations on how to treat glaucoma among pregnant women. As we know, eye pressure is progressively going down from the first to the third trimester, so we often have to correct hypotensive therapy. Besides, it is necessary to take into account the effect of applied medicines on mother health and evaluate possible teratogenic complications for a fetus. The only medicine against glaucoma which belongs to category B according to FDA classification is brimonidine. Medicines of the other groups should be prescribed with care. Laser treatment or surgery may also be a relevant decision when monitoring patients who are planning pregnancy or just bearing a child. Such treatment should be also accompanied by medicines.

The impact of maternal obesity on fetal adiposity in the third trimester

2010 ◽  
Vol 95 (Supplement 1) ◽  
pp. Fa25-Fa25
Author(s):  
N. Farah ◽  
M. Kennelly ◽  
V. Donnelly ◽  
B. Stuart ◽  
M. Turner
Keyword(s):  
Maternal Obesity ◽  
Third Trimester ◽  
The Third ◽  
The Impact

scholarly journals A systematic review and meta-analysis of prevalence of insomnia in the third trimester of pregnancy

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nader Salari ◽  
Niloofar Darvishi ◽  
Behnam Khaledi-Paveh ◽  
Aliakbar Vaisi-Raygani ◽  
Rostam Jalali ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Sleep Disorders ◽  
Sleep Disturbances ◽  
Meta Analysis ◽  
Physical And Mental Health ◽  
Third Trimester ◽  
Cross Sectional ◽  
The Third ◽  
Physical Problems ◽  
Meta Regression Analysis

Abstract Background Sleep disorders, which are among the foremost important medical care issues, are prevalent in pregnancy. The present study is a meta-analysis of the prevalence of insomnia in the third trimester of pregnancy. This study aims to systematically review the overall prevalence of insomnia in the third trimester of pregnancy through conducting a meta-analysis. Method The literature used in this meta-analysis for the topic discussed above were obtained through searching several databases, including SID, MagIran, IranDoc, Scopus, Embase, Web of Science (WoS), PubMed Science Direct and Google Scholar databases without time limitation until December 2020. Articles developed based on cross-sectional studies were included in the study. The heterogeneity of studies was investigated using the I2 index. Also, the possible effects of heterogeneity in the studied studies are investigated using meta-regression analysis. Result In 10 articles and 8798 participants aged between11–40, the overall prevalence of insomnia in the third trimester of pregnancy based on meta-analysis was 42.4% (95% CI: 32.9–52.5%). It was reported that as the sample size increases, the prevalence of insomnia in the third trimester of pregnancy increases. Conversely, as the year of research increases, the prevalence of insomnia in the third trimester of pregnancy decreases. Both of these differences were statistically significant (P < 0.05). Conclusion Insomnia was highly prevalent in the last trimester of pregnancy. Sleep disorders are neglected among pregnant women, and they are considered natural. While sleep disturbances can cause mental and physical problems in pregnant women, they can consequently cause problems for the fetus. As a result, maintaining the physical and mental health of pregnant mothers is very important. It is thus recommended that in addition to having regular visits during pregnancy, pregnant women should also be continuously monitored for sleep-related disorders.

The sFlt-1 to PlGF Ratio in Pregnant Women with Rheumatoid Arthritis: Impact of Disease Activity and Sulfasalazine Use

Rheumatology ◽  
2021 ◽  
Author(s):  
Rugina I Neuman ◽  
Hieronymus T W Smeele ◽  
A H Jan Danser ◽  
Radboud J E M Dolhain ◽  
Willy Visser
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Disease Activity ◽  
Pregnant Women ◽  
Gestational Age ◽  
Third Trimester ◽  
Low Disease Activity ◽  
The Third ◽  
Observational Prospective Cohort Study ◽  
Plgf Ratio

Abstract Objectives An elevated sFlt-1/PlGF-ratio has been validated as a significant predictor of preeclampsia, but has not been established in women with rheumatoid arthritis (RA). We explored whether the sFlt-1/PlGF-ratio could be altered due to disease activity in RA, and could be applied in this population to predict preeclampsia. Since sulfasalazine has been suggested to improve the angiogenic imbalance in preeclampsia, we also aimed to examine whether sulfasalazine could affect sFlt-1 or PlGF levels. Methods Making use of a nationwide, observational, prospective cohort study on pregnant women with RA, sFlt-1 and PlGF were measured in the third trimester. A total of 221 women, aged 21–42 years, were included, with a median gestational age of 30 + 3 weeks. Results No differences in sFlt-1 or PlGF were observed between women with high, intermediate or low disease activity (p= 0.07 and p= 0.41), whereas sFlt-1 and PlGF did not correlate with DAS28-CRP score (r=-0.01 and r=-0.05, respectively). Four (2%) women with a sFlt-1/PlGF-ratio ≤38 developed preeclampsia in comparison to three (43%) women with a ratio &gt; 38, corresponding to a negative predictive value of 98.1%. Sulfasalazine users (n = 57) did not show altered levels of sFlt-1 or PlGF in comparison to non-sulfasalazine users (n = 164, p= 0.91 and p= 0.11). Conclusion Our study shows that in pregnant women with RA, the sFlt-1/PlGF-ratio is not altered due to disease activity and a cut-off ≤38 can be used to exclude preeclampsia. Additionally, sulfasalazine use did not affect sFlt-1 or PlGF levels in this population.

scholarly journals Health anxiety and related factors among pregnant women during the COVID-19 pandemic: a cross-sectional study from Iran

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Najmieh Saadati ◽  
Poorandokht Afshari ◽  
Hatam Boostani ◽  
Maryam Beheshtinasab ◽  
Parvin Abedi ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Health Care Providers ◽  
Health Anxiety ◽  
Cross Sectional Study ◽  
Care Providers ◽  
Sectional Study ◽  
Third Trimester ◽  
Related Factors ◽  
Cross Sectional ◽  
The Third

Abstract Background The COVID-19 pandemic has affected many countries around the world and Iran was no exception. The aim of this study was to evaluate health anxiety of Iranian pregnant women during the COVID-19 pandemic. Methods In this cross-sectional study, 300 pregnant women in different trimesters (n = 100 in each trimester) were recruited. A demographic questionnaire and the Health Anxiety Questionnaire were used to collect data. Scores of < 27, 27–34 and more than 35 were defined as low, moderate and high health anxiety, respectively. Due to nationwide restrictions, data were collected through social media groups. Chi-square tests, ANOVA and multiple linear regression were used to analyze the data. Results Mean (SD) total anxiety scores were 22.3 ± 9.5, 24.6 ± 9.3 and 25.4 ± 10.6 in the first, second and third trimesters of pregnancy, respectively. 9, 13 and 21% of women had severe anxiety in the first, second and third trimesters of pregnancy, respectively. Women in the third trimester had significantly higher health anxiety scores than those in the first trimester (p = 0.045). Conclusion At the time of the COVID-19 pandemic, women in the second and third trimesters of pregnancy were more worried about consequences of disease, but total health anxiety scores were significantly higher among women in the third trimester of pregnancy. Health care providers should pay more attention to the mental health of pregnant women in times of crises such as the COVID-19 pandemic.

Sign in / Sign up

Export Citation Format

Share Document